前列腺增生合并浅表性膀胱癌的同期手术治疗  

Simultaneous surgical management of Benign prostatic hyperplasia and bladder tumor.

作　　者：李建勇[1] 程树林[1] 陈双全[1] 廖波[1] 

机构地区：[1]川北医学院附属医院泌尿外科,四川南充637000

出　　处：《四川医学》2013年第8期1116-1117,共2页Sichuan Medical Journal

摘　　要：目的探讨良性前列腺增生合并浅表性膀胱癌同期手术的安全性和有效性。方法 35例浅表性膀胱癌合并前列腺增生症患者同期行经尿道前列腺及膀胱肿瘤等离子电切术并随访观察疗效。结果所有患者手术顺利,术后6个月患者国际前列腺症状评分由术前的（23.6±7.2）下降至（10.1±0.9）,最大尿流率由术前的（5.6±3.4）ml/s提高至（15.2±3.8）ml/s,差异有统计学意义（P〈0.05）。随访6~50个月,3例膀胱肿瘤复发,均未在后尿道、前列腺窝。结论同期经尿道等离子电切术治疗膀胱癌合并前列腺增生安全、有效,不增加前列腺窝及后尿道肿瘤种植的风险,减轻了患者分期手术的痛苦和经济负担,提高了生活质量。Objective To evaluate the efficacy and safety of simultaneous transurethral resection for patients with benign prostatic hyperplasia（BPH） and bladder transitional cell carcinoma.Methods 35 patients with bladder transitional cell carcinoma and BPH were treated by transurethral plasmakinetic resection at the same time.All patients were follewed up.Results No transurethral resection syndrome occurred in those patients.The peak flow rate increased from（5.6 ±3.4） mL / s to（（15.2 ±3.8）） mL / s,the international prostate symptom score（IPSS） decreased from（23.6±7.2） to（10.1±0.9） at postoperative 6 months respectively and made differnce P〈0.05.The patients were followed up ranged from 6 - 50 months.3 cases showed rucurent bladder tumors.Conclusion Transurethral plasmakinetic resection simultaneous is safe and effective for the patients with bladder tumor coexisting BPH,while no effect on incidence of implantation in bladder neck and prostatic fossa.

关 键 词：膀胱肿瘤 前列腺增生 前列腺电切 

分 类 号：R697.32[医药卫生—泌尿科学]